🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Response and Content Removal

Based on the social media company, the platform has removed violative content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, glowing reviews and detailed instructions for mixing or injecting at home.

Within moments of joining one group, a vendor shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts show dark colored packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to potentially serious medical dangers”.